Antitumor necrosis factor therapy for inflammatory bowel disease: A review of agents, pharmacology, clinical results, and safety

This publication has 57 references indexed in Scilit:

• Reduction of Circulating Secretory Phospholipase A₂Levels by Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody in Patients with Severe Crohn's Disease
  Scandinavian Journal of Gastroenterology, 1998
• EVALUATION OF RECOMBINANT HUMAN SOLUBLE DIMERIC TUMOR NECROSIS FACTOR RECEPTOR FOR PREVENTION OF OKT3-ASSOCIATED ACUTE CLINICAL SYNDROME1,2
  Transplantation, 1996
• THE THERAPEUTIC EFFECTS OF AN ENGINEERED HUMAN ANTI-TUMOUR NECROSIS FACTOR ALPHA ANTIBODY (CDP571) IN RHEUMATOID ARTHRITIS
  Rheumatology, 1995
• Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
  Arthritis & Rheumatism, 1993
• Construction and initial characterization of a mouse-human chimeric anti-TNF antibody
  Molecular Immunology, 1993
• Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea.
  Journal of Clinical Pathology, 1993
• Humanized antibodies
  Immunology Today, 1993
• Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation.
  Gut, 1992
• Tumor necrosis factor-?, interleukin-1?, and interleukin-6 expression in inflammatory bowel disease
  Digestive Diseases and Sciences, 1992
• Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine
  Clinical and Experimental Immunology, 1990